Match tier
Listed
Presence
Current · Arkansas
Last published
2024
Sources
OpenAlex · ORCID
Refreshed
2026-08-18
W
Wesley A. Bland
Researcher
Also affiliated: University of North Carolina at Chapel Hill (2024); North Carolina Department of Environmental Quality (2024)
Graduate Student Researcher
1 h-index
3 pubs
8 cited
Research Areas
Biography and Research Information
OverviewAI-generated summary
Wesley A. Bland's research focuses on the development and evaluation of vaccines against gammaherpesviruses. His work has investigated replication-deficient gammaherpesvirus vaccines, demonstrating their ability to protect mice from lytic disease and reduce the establishment of latency. This research also showed protection against acute replication, reactivation from latency, and lethal challenges in mouse models. Bland has co-authored three publications with collaborators J. Craig Forrest and Shana M. Owens at the University of Arkansas for Medical Sciences, with his most recent publication in 2024. His scholarly output includes an h-index of 1, with a total of three publications and six citations.
Metrics
- h-index: 1
- Publications: 3
- Citations: 8
Selected Publications
-
A replication-deficient gammaherpesvirus vaccine protects mice from lytic disease and reduces latency establishment (2024)
-
Replication-dead gammaherpesvirus vaccine protects against acute replication, reactivation from latency, and lethal challenge in mice (2023)
Collaboration Network
Top Collaborators
Shana M. Owens
University of Arkansas for Medical Sciences
2 shared publications
In database
- A replication-deficient gammaherpesvirus vaccine protects mice from lytic disease and reduces latency establishment
- Replication-dead gammaherpesvirus vaccine protects against acute replication, reactivation from latency, and lethal challenge in mice
Kyle McEvoy
Stony Brook University (US)
2 shared publications
- A replication-deficient gammaherpesvirus vaccine protects mice from lytic disease and reduces latency establishment
- Replication-dead gammaherpesvirus vaccine protects against acute replication, reactivation from latency, and lethal challenge in mice
Chad H. Hogan
National Cancer Institute (US)
2 shared publications
- A replication-deficient gammaherpesvirus vaccine protects mice from lytic disease and reduces latency establishment
- Replication-dead gammaherpesvirus vaccine protects against acute replication, reactivation from latency, and lethal challenge in mice
Luciarita Boccuzzi
Rush University Medical Center (US)
2 shared publications
- A replication-deficient gammaherpesvirus vaccine protects mice from lytic disease and reduces latency establishment
- Replication-dead gammaherpesvirus vaccine protects against acute replication, reactivation from latency, and lethal challenge in mice
Varvara Kirillov
Stony Brook University (US)
2 shared publications
- A replication-deficient gammaherpesvirus vaccine protects mice from lytic disease and reduces latency establishment
- Replication-dead gammaherpesvirus vaccine protects against acute replication, reactivation from latency, and lethal challenge in mice
Camille Khairallah
Stony Brook University (US)
2 shared publications
- A replication-deficient gammaherpesvirus vaccine protects mice from lytic disease and reduces latency establishment
- Replication-dead gammaherpesvirus vaccine protects against acute replication, reactivation from latency, and lethal challenge in mice
Brian S. Sheridan
Stony Brook University (US)
2 shared publications
- A replication-deficient gammaherpesvirus vaccine protects mice from lytic disease and reduces latency establishment
- Replication-dead gammaherpesvirus vaccine protects against acute replication, reactivation from latency, and lethal challenge in mice
J. Craig Forrest
Winthrop Rockefeller Foundation
2 shared publications
In database
- A replication-deficient gammaherpesvirus vaccine protects mice from lytic disease and reduces latency establishment
- Replication-dead gammaherpesvirus vaccine protects against acute replication, reactivation from latency, and lethal challenge in mice
Laurie T. Krug
Stony Brook School (US)
2 shared publications
- A replication-deficient gammaherpesvirus vaccine protects mice from lytic disease and reduces latency establishment
- Replication-dead gammaherpesvirus vaccine protects against acute replication, reactivation from latency, and lethal challenge in mice
Dipanwita Mitra
National Cancer Institute (US)
1 shared publication
- A replication-deficient gammaherpesvirus vaccine protects mice from lytic disease and reduces latency establishment
Thomas J. Meyer
National Institutes of Health (US)
1 shared publication
- A replication-deficient gammaherpesvirus vaccine protects mice from lytic disease and reduces latency establishment
Similar Researchers
Based on overlapping research topics
Adnan Al- Rubaee
University of Arkansas at Fayetteville
Microbial infections and disease research
Immune Response and Inflammation
Genomics and Phylogenetic Studies
Jody Sorenson
University of Arkansas at Little Rock
Microbial infections and disease research
Immune Response and Inflammation
Genomics and Phylogenetic Studies
Jia Liu
University of Arkansas for Medical Sciences
Microbial infections and disease research
Immune Response and Inflammation
Genomics and Phylogenetic Studies
Jason Liem
University of Arkansas for Medical Sciences
Microbial infections and disease research
Immune Response and Inflammation
Genomics and Phylogenetic Studies
Jonathan J. Bauer
University of Arkansas for Medical Sciences
Microbial infections and disease research
Immune Response and Inflammation
Vaccine Coverage and Hesitancy
K K Laffoon
University of Arkansas for Medical Sciences
Microbial infections and disease research
Immune Response and Inflammation
Genomics and Phylogenetic Studies